Skip to content

Comparative Study of the Combination of Different Modes of Administration of Local Anesthetics in Labor Analgesia

Comparative Study of the Combination of Different Modes of Administration of Local Anesthetics in Labor Analgesia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03839056
Enrollment
151
Registered
2019-02-15
Start date
2015-08-02
Completion date
2019-02-28
Last updated
2020-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor Epidural Analgesia

Keywords

epidural local anesthetic, epidural analgesia, analgesia labor

Brief summary

The investigators have design an observational study to know the anesthetic consumption in terms of rescue analgesia (Patient Controlled Epidural Analgesia (PCEA) and manual boluses) of the combination of different modes of administration of local anesthetic in the epidural space during labor analgesia offered by the new version of the CADD® infusion pump. Also in this pump the anesthetic can be administered across a system of standard flow (40-250ml/h) or of high flow (40-500ml/h), what according to studies can influence the diffusion epidural of the anesthetic and therefore the level of sensitive blockade.

Detailed description

The study is designed with healthy patients, first-time mothers, in childbearing dynamics, term pregnancy and nullipary. The epidural technique was performed with dose test of 3ml of bupivacaína 0,25 % with vasoconstrictor and a manual bolus of 0,1ml/Kg of ropivacaína 0,2% with fentanilo 5ug/ml. As soon as the informed consent about the epidural anesthesia was signed, the patient was informed of the possibility of taking part in the study and there is offered him the sheet of information of the patient. So in one group they were administered Programed Intermittent Epidural Boluses (PIEB) and in other group continuous Epidural Infusion (IC) plus PIEB according to the usual clinical practice of each anesthesiologist. In both cases the perfusion was of ropivacaína 0,1 % more fentanilo 2ug/ml, so that in the first group it was administered PIEB of 10ml every hour and in the second group a continuous infusion to 3ml/h plus PIEB of 7ml every hour. Also if during the period of dilatation an AVE (Analogical Visual Escale) greater than or equal to 4 appeared (inadequate analgesia) the patient could administer a 5ml PCEA bolus of the same solution (interval of closing of 20min and maximum dose for hour of 15ml), as it is done in according to the usual clinical practice. And if after two boluses of PCEA the analgesia was still ineffective a clinical bolus of 4ml of lidocaína to 1 % was administered by the anesthesiologist. In addition, in the group that was administered only PIEB, the standard infusion system was compared with the high-flow infusion system. In all patients it was evaluated and noted on the epidural record sheet the intensity of the pain as the analogical visual scale (AVE), the grade of motor blockade as the modified scale of Bromage and the sensitive level in different periods of time. Also registered the total doses of anesthetic, the way of the childbearing finishes, the Apgar of the newborn, the grade of maternal satisfaction and the side effects. Also through the software of the pump it was verified if the patient had been administered rescue analgesia (PCEA or clinical boluses).

Interventions

DEVICEIC+PIEB+PCEA high flow

Ropivacaina 0,1 % is used with fentanilo 2ug/ml Also if during the dilation period a greater or equal AVE appears to 4 (inadequate analgesia) the patient can be administered a bolus of PCEA of the same solution. If the patient is administered PCEA, the programed intermittent epidural bolus is delayed automatically 20 minutes with regard to the time in which it would have to be administrated. If after two bolus of PCEA the analgesia keeps on being ineffective a clinical bolus is administered by the anaesthetist of 4ml of lidocaína to 1 %. This intervention is included in the clinical practice routine

DEVICEPIEB+PCEA high flow

Ropivacaina 0,1 % is used with fentanilo 2ug/ml Also if during the dilation period a greater or equal AVE appears to 4 (inadequate analgesia) the patient can be administered a bolus of PCEA of the same solution. If the patient is administered PCEA, the programed intermittent epidural bolus is delayed automatically 20 minutes with regard to the time in which it would have to be administrated. If after two bolus of PCEA the analgesia keeps on being ineffective a clinical bolus is administered by the anaesthetist of 4ml of lidocaína to 1 %. In the group of pure boluses 10ml / h of perfusion will be administered through the high flow and standard flow infusion system, and the maximum sensory level achieved will be compared. This intervention is included in the clinical practice routine

DEVICEPIEB+PCEA standar flow

Ropivacaina 0,1 % is used with fentanilo 2ug/ml Also if during the dilation period a greater or equal AVE appears to 4 (inadequate analgesia) the patient can be administered a bolus of PCEA of the same solution. If the patient is administered PCEA, the programed intermittent epidural bolus is delayed automatically 20 minutes with regard to the time in which it would have to be administrated. If after two bolus of PCEA the analgesia keeps on being ineffective a clinical bolus is administered by the anaesthetist of 4ml of lidocaína to 1 %. In the group of pure boluses 10ml / h of perfusion will be administered through the high flow and standard flow infusion system, and the maximum sensory level achieved will be compared. This intervention is included in the clinical practice routine

Sponsors

Hospital Universitario de la Plana
CollaboratorOTHER
Marian Daras
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Pregnant women in work of established labor and contractions of moderate intensity * Age between 18 and 45 years * ASA I and II * Nulliparity * Pregnancy to term (\> 36semanas) * The only fetus of cephalic presentation * Cervical dilation between 2-5cm

Exclusion criteria

* Maternal systemic illness (Diabetes Mellitus, arterial Hypertension, Preeclampsia. . ) * Major or equal weight to 100 Kg * Less height of 150cm * Duration of the equal or major childbearing to 24h * Administration of opioides parenterales in 2-4h before to performing of the epidural * Contraindication for neuroaxial analgesia * Precedents of allergy or hypersensitivity to anesthetic local

Design outcomes

Primary

MeasureTime frameDescription
anesthetic consumption in millilitersat the end of labourThe anesthetic consumption in terms of analgesia of rescue of the combination of different ways of administration of anesthetic in the space epidural. The quantity of extra analgesic is already by means of boluses of PCEA or by means of clinical boluses measured in milliliters

Secondary

MeasureTime frameDescription
Motor blockade from zero to fourBaseline (just after epidural administration)The grade of motive blockade registers according to the modified scale of Bromage (from 0 to 3): 0 = it can raise the low extremities of the bed 1. = it can bend knees and ankles 2. = it can bend ankles but not the knees 3. = it can bend neither ankles nor knees
analgesic effectiveness with AVEBaseline (just after epidural administration)Measurement by means of the evaluation of the intensity of the pain that will be evaluated according to the analogical visual scale (AVE) with values between 0 and 10
Sensitive blockade from T12 to T4Baseline (just after epidural administration)The sensory level reached will be valued according to the loss of sensibility to the cold by means of a cotton with alcohol, noting down the dermatoma where it does not exist or diminishes the sensibility (T4: nipples level, T10: level of the bellybutton, T12: groin region). For statistical analysis of this variable a numerical value was given to each dermatome so that the highest value represents a higher sensory level and therefore more dermatomes with sensitive block (T12 = 0 and T4 = 8).
Blood pressureBaseline (just after epidural administration)The patient will be evaluated and there will register the blood pressure in mm of mercury
Maternal heart rateBaseline (just after epidural administration)The patient will be evaluated and there will register the maternal heart rate in beats per minute
maternal satisfactionat the end of laborOn having finished the childbearing, from 0 to 100 will value the grade of maternal satisfaction as an evaluation scale: * 0 = very unsatisfied with the analgesia provided by the treatment * 100 = extremely satisfied with the analgesia provided by the treatment
adverse effectsat the end of laborThere will be noted down also the appearance of adverse effects as the sickness and vomiting, urinal retention, pruritus and fever.

Other

MeasureTime frameDescription
ASA from one to fiveJust before epidural administrationThe ASA classification will be noted on the epidural record sheet
Gestational week in numberJust before epidural administrationThe Gestational week in number will be noted on the epidural record sheet
Cervical dilatation at the time of performing the epidural technique in centimetersJust before epidural administrationThe dilatation in centimeters will be noted on the epidural record sheet
Administration of parenteral opioids and the time of administrationJust before epidural administrationIn the epidural record sheet if opioids have been administered it will be recorded as YES and if they have not been administered it will be recorded as NO. If it has been administered, the time of its admnistracion will be indicated numerically
Size in centimetersJust before epidural administrationThe height in centimeters will be noted on the epidural record sheet
Weight in kilogramsJust before epidural administrationThe weight in kilograms will be noted on the epidural record sheet

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026